BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7825188)

  • 1. Behavioural effects of norpethidine, a metabolite of pethidine, in rats.
    Plummer JL; Gourlay GK; Cmielewski PL; Odontiadis J; Harvey I
    Toxicology; 1995 Jan; 95(1-3):37-44. PubMed ID: 7825188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of pethidine and norpethidine in cerebrospinal fluid of man following intramuscular injection of pethidine.
    Boréus LO; Sköldefors E; Ehrnebo M
    Acta Anaesthesiol Scand; 1983 Jun; 27(3):222-5. PubMed ID: 6880582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of pethidine (meperidine), phenoperidine, and norpethidine (normeperidine), their common metabolite, by gas chromatography with selective nitrogen detection.
    Kintz P; Godelar B; Mangin P; Lugnier AA; Chaumont AJ
    Forensic Sci Int; 1989 Dec; 43(3):267-73. PubMed ID: 2613140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of therapeutic plasma concentrations of pethidine and norpethidine in man by electron capture gas chromatography.
    Hartvig P; Karlsson KE; Lindbert C; Boréus LO
    Eur J Clin Pharmacol; 1977; 11(1):65-9. PubMed ID: 832660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
    Kishimoto O
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of formation of norpethidine from pethidine.
    Austin KL; Stapleton JV; Mather LE
    Br J Anaesth; 1981 Mar; 53(3):255-8. PubMed ID: 7470361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between dextromethorphan and norpethidine in rats.
    Plummer JL; Tran KD; Gourlay GK
    Eur J Pain; 1997; 1(3):191-6. PubMed ID: 15102400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF and plasma pharmacokinetics of pethidine and norpethidine in man after epidural and intrathecal administration of pethidine.
    Nordberg G; Hansdottir V; Bondesson U; Boréus LO; Mellstrand T; Hedner T
    Eur J Clin Pharmacol; 1988; 34(6):625-31. PubMed ID: 3169113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
    Tang AH; Himes CS
    Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of pethidine of abuse and relevant metabolite norpethidine in urine by ultra-performance liquid chromatography-tandem mass spectrometry.
    Kul A; Ozdemir M; Sagirli O
    J Pharm Biomed Anal; 2020 Jul; 186():113320. PubMed ID: 32387748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lead exposure on licking and yawning behaviour in rats.
    Ghazi-Khansari M; Rezvani N; Bani-Assadi S; Zarrindast MR
    Pharmacol Toxicol; 1998 Sep; 83(3):120-4. PubMed ID: 9783330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The simultaneous determination of pethidine and norpethidine in biofluids by nitrogen selective gas chromatography.
    Tse J; Chan K
    Methods Find Exp Clin Pharmacol; 1981; 3(2):99-104. PubMed ID: 7230982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norpethidine toxicity and patient controlled analgesia.
    Stone PA; Macintyre PE; Jarvis DA
    Br J Anaesth; 1993 Nov; 71(5):738-40. PubMed ID: 8251291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and analgesic effect of pethidine (meperidine) and its metabolites in the rat.
    Dahlström BE; Paalzow LK; Lindberg C; Bogentoft C
    Drug Metab Dispos; 1979; 7(2):108-12. PubMed ID: 38072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of pethidine and norpethidine in mouse plasma by liquid chromatography-electrospray ionization source-mass spectrometry.
    Zhang C; Li X; Xu Y; Wu T; Ren X; Liu D
    J Anal Toxicol; 2013; 37(6):351-6. PubMed ID: 23719316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.